| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/05/2009 | CN100522972C Fused heterocyclic isoxazoline derivatives and their use as anti-depressants |
| 08/05/2009 | CN100522967C Phosphorus-containing compounds & uses thereof |
| 08/05/2009 | CN100522962C 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| 08/05/2009 | CN100522961C Amide substituted xanthine derivatives with gluconeogenesis modulating activity |
| 08/05/2009 | CN100522946C Stabilization of hypoxia inducible factor (HIF) alpha |
| 08/05/2009 | CN100522945C Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and use thereof |
| 08/05/2009 | CN100522944C Carboxylic acid derivative and thereof |
| 08/05/2009 | CN100522943C Vitamin d analogues |
| 08/05/2009 | CN100522940C Derivatives of alpha-phenylthiocarboxylic and g(a)-phenyloxy-carboxylic acids useful for the treatment of diseases responding to PPAR alpha activation |
| 08/05/2009 | CN100522230C Medicine for treating diabetes and hephrosis and its preparing method |
| 08/05/2009 | CN100522204C A Chinese medicine for treating hypertension and hyperlipemia and method for preparing same |
| 08/05/2009 | CN100522203C Medicine for treating hyperlipidemia and its preparation method |
| 08/05/2009 | CN100522197C Chinese-medicinal preparation for treating high blood fat and its making method |
| 08/05/2009 | CN100522196C Medicine or foods for prevention and treatment of microcirculation disorder and disease of live habits |
| 08/05/2009 | CN100522166C (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists |
| 08/05/2009 | CN100522164C Method of treating of demyelinating diseases or conditions |
| 08/05/2009 | CN100522159C The use of substituted azetidinone compounds for the treatment of sitosterolemia |
| 08/05/2009 | CN100522157C Treatment of diseases involving defective gap junctional communication |
| 08/05/2009 | CN100522155C Use of retigabin for treating neuropathic pain |
| 08/05/2009 | CN100522151C Compounds for treatment of inflammation, diabetes and related disorders |
| 08/05/2009 | CN100521972C Composition for promotion of bone growth and maintenance of bone health |
| 08/05/2009 | CN100521969C Herbal nutraceutical formulation for females/expectant mothers and its process of preparation |
| 08/04/2009 | US7569592 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
| 08/04/2009 | US7569585 Drugs; analgesics; anesthetics; antiarrhythmia agents; antiinflammatory agents ; incontinence; gastrointestinal disorders; neurodegenerative disease |
| 08/04/2009 | US7569574 Purine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 08/04/2009 | US7569569 Pyrrolo[2,3-d]pyrimidine compounds |
| 08/04/2009 | US7569567 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-B]indole-1-carboxamide derivatives, their preparation and therapeutic use |
| 08/04/2009 | CA2536251C Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| 08/04/2009 | CA2434228C Biphenyl derivatives |
| 08/04/2009 | CA2433785C Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 08/04/2009 | CA2424566C Dental care compositions |
| 08/04/2009 | CA2365281C Human antibodies that bind human il-12 and methods for producing |
| 08/04/2009 | CA2356212C Crystalline bis[(e)-7- [ 4-(4- fluorophenyl)- 6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin -5-yl] (3r,5s)-3, 5-dihydroxyhept -6-enoic acid]calcium salt |
| 08/04/2009 | CA2272237C Film coatings and film coating compositions based on dextrin |
| 08/04/2009 | CA2201115C Hydration compositions for human or animal bodies |
| 07/30/2009 | WO2009093990A1 Benzimidazole derivatives and the use thereof |
| 07/30/2009 | WO2009093776A1 Method for the preparation of atorvastatin and intermediates used therein |
| 07/30/2009 | WO2009093755A1 Agent for increasing blood adiponectin quantity |
| 07/30/2009 | WO2009093737A1 Anti-obesity pharmaceutical composition |
| 07/30/2009 | WO2009093736A1 Tablet comprising kanpo herbal medicine and pantethine component |
| 07/30/2009 | WO2009093595A1 Method for producing carotenoid-containing emulsion composition, carotenoid-containing emulsion composition obtained by the same, carotenoid-containing powder composition, and functional food and cosmetic preparation each containing the composition |
| 07/30/2009 | WO2009093534A1 Vegfc production promoter |
| 07/30/2009 | WO2009093471A1 Apoptosis inhibitor |
| 07/30/2009 | WO2009093454A1 Food composition, feed composition comprising the food composition, and method for feeding animal by using the feed composition |
| 07/30/2009 | WO2009093384A1 Polynucleotide or analogue thereof, and gene expression regulation method using the polynucleotide or the analogue thereof |
| 07/30/2009 | WO2009093269A1 Novel heterocyclic compounds |
| 07/30/2009 | WO2009093264A2 Pharmaceutical combinations comprising specified age breaker and further drugs, i.a. antihypertensive drugs, antidiabetic drugs etc. |
| 07/30/2009 | WO2009093018A1 New use for cannabinoids |
| 07/30/2009 | WO2009092284A1 Benzocycloheptene derivatives, preparing processes and pharmaceutical uses thereof |
| 07/30/2009 | WO2009092133A1 Methods for identifying compounds capable of treating or preventing a diabetic complication via set7 or suv39 methyltransferases |
| 07/30/2009 | WO2009055331A3 Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119 |
| 07/30/2009 | WO2009053725A3 Peptides and uses thereof |
| 07/30/2009 | WO2009050595A3 An improved process for preparing a 2,4-thiazolidinedione derivative |
| 07/30/2009 | WO2009043464A3 Astressin and beta- endorphin for use as therapeutic agents |
| 07/30/2009 | WO2009043451A3 Use of chorionic gonadotropin-beta (109-145) as a therapeutic agent |
| 07/30/2009 | WO2009043450A3 Use of neurotrophic factor for retinal cholinergic neurons (nfrcn) and chorionic gonadotropin-beta (109-145) as therapeutic agents |
| 07/30/2009 | WO2009043449A3 Use of a peptide as a therapeutic agent |
| 07/30/2009 | WO2009043447A3 Use of a peptide as a therapeutic agent |
| 07/30/2009 | WO2009040004A3 Use of a peptide as a therapeutic agent |
| 07/30/2009 | WO2009033813A3 Use of a peptide as a therapeutic agent |
| 07/30/2009 | WO2009033774A3 Use of a laminin nonapeptide as a therapeutic agent |
| 07/30/2009 | WO2009033769A3 Use of cortistatin 14 and others as a therapeutic agent |
| 07/30/2009 | WO2009033722A8 Use of a octreotide as a therapeutic agent |
| 07/30/2009 | WO2009013633A4 Amorphous coprecipitates of atorvastatin pharmaceutically acceptable salts |
| 07/30/2009 | WO2008087560A9 Thiazolidine derivatives and methods for the preparation thereof |
| 07/30/2009 | WO2008076810A9 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 07/30/2009 | WO2008071169A3 Method for the production of specific inhibitors of 11-beta-hydroxysteroid dehydrogenase, in particular type 1 with basic nor-oleanan or nor-ursan frameworks |
| 07/30/2009 | WO2008052044A3 Use of derivatives of propofol for treating diseases associated with oxidative stress |
| 07/30/2009 | WO2007112753A8 Pharmaceutical composition comprising anti-mirna antisense oligonucleotides |
| 07/30/2009 | US20090192218 Use of phthalide derivatives for the treatment and prevention of diabetes mellitus |
| 07/30/2009 | US20090192204 N-(2-thiazolyl)-amide derivatives as gsk-3 inhibitors |
| 07/30/2009 | US20090192197 Antibiotics with improved solubility, lower toxicity; potent antibacterial activity; includes Torezolid phosphate |
| 07/30/2009 | US20090192188 Tetrahydroisoquinoline derivatives |
| 07/30/2009 | US20090192162 Phenoxy Acetic Acids as PPAR Delta Activators |
| 07/30/2009 | US20090192143 Substituted diazepan orexin receptor antagonists |
| 07/30/2009 | US20090192138 compounds |
| 07/30/2009 | US20090192132 Pharmaceutical Composition |
| 07/30/2009 | US20090192131 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism |
| 07/30/2009 | US20090192129 Bicyclic pyrrole derivatives |
| 07/30/2009 | US20090192121 Novel bisamidate phosphonate prodrugs |
| 07/30/2009 | US20090192109 Compositions for diagnosis and therapy of diseases associated with aberrant expression of Kremen and/or Wnt |
| 07/30/2009 | US20090192105 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCELIC ACID (siNA) |
| 07/30/2009 | US20090192088 Vascular Endothelial Growth Factor 2 |
| 07/30/2009 | US20090192087 Methods and Compositions Using Klotho-FGF Fusion Polypeptides |
| 07/30/2009 | US20090192081 Casein derived peptides and uses thereof |
| 07/30/2009 | US20090192080 Cerberus/coco derivatives and uses thereof |
| 07/30/2009 | US20090192075 Amylin Formulations |
| 07/30/2009 | US20090192072 Insulin and IGF-1 Receptor Agonists and Antagonists |
| 07/30/2009 | US20090191624 Use of transthyretin peptide/protein fussions to increase the serum half-life of pharmacologically active peptides/proteins |
| 07/30/2009 | US20090191572 Imaging, diagnosis and treatment of disease |
| 07/30/2009 | US20090191294 Grape cane product, and method of making |
| 07/30/2009 | US20090191272 Use of vegetable fine grain sized fibres for preparing a nutritional composition for reducing mycotoxin bioavailability |
| 07/30/2009 | US20090191167 Adult sertoli cells and uses thereof |
| 07/30/2009 | US20090191159 Multipotent/pluripotent cells and methods |
| 07/30/2009 | US20090191146 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 07/30/2009 | DE4245089B4 Oral pharmaceutical compsn. for treating hyperlipoproteinaemia or atherosclerosis - comprises hydroxymethyl glutaryl coenzyme A reductase cholesterol inhibitor |
| 07/30/2009 | CA2749742A1 3-(sulfonyl)pyrazolo[1,5-a]pyrimidines - antagonists of serotonin 5-ht6 receptors, methods for their preparation and use |
| 07/30/2009 | CA2712685A1 Novel heterocyclic compounds |
| 07/30/2009 | CA2711873A1 New use for cannabinoids |
| 07/30/2009 | CA2711576A1 Tricyclic compounds as modulators of tnf-.alpha. synthesis and as pde4 inhibitors |